Choi Won Seok, Han Dong Soo, Eun Chang Soo, Park Dong Il, Byeon Jeong-Sik, Yang Dong-Hoon, Jung Sung-Ae, Lee Sang Kil, Hong Sung Pil, Park Cheol Hee, Lee Suck-Ho, Ji Jeong-Seon, Shin Sung Jae, Keum Bora, Kim Hyun Soo, Choi Jung Hye, Jung Sin-Ho
Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea.
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
Intest Res. 2018 Jan;16(1):126-133. doi: 10.5217/ir.2018.16.1.126. Epub 2018 Jan 18.
BACKGROUND/AIMS: Colonoscopic surveillance is currently recommended after polypectomy owing to the risk of newly developed colonic neoplasia. However, few studies have investigated colonoscopy surveillance in Asia. This multicenter and prospective study was undertaken to assess the incidence of advanced adenoma based on baseline adenoma findings at 3 years after colonoscopic polypectomy.
A total of 1,323 patients undergoing colonoscopic polypectomy were prospectively assigned to 3-year colonoscopy surveillance at 11 tertiary endoscopic centers. Relative risks for advanced adenoma after 3 years were calculated according to baseline adenoma characteristics.
Among 1,323 patients enrolled, 387 patients (29.3%) were followed up, and the mean follow-up interval was 31.0±9.8 months. The percentage of patients with advanced adenoma on baseline colonoscopy was higher in the surveillance group compared to the non-surveillance group (34.4% vs. 25.7%). Advanced adenoma recurrence was observed in 17 patients (4.4%) at follow-up. The risk of advanced adenoma recurrence was 2 times greater in patients with baseline advanced adenoma than in those with baseline non-advanced adenoma, though the difference was not statistically significant (6.8% [9/133] vs. 3.1% [8/254], =0.09). Advanced adenoma recurrence was observed only in males and in subjects aged ≥50 years. In contrast, adenoma recurrence was observed in 187 patients (48.3%) at follow-up. Male sex, older age (≥50 years), and multiple adenomas (≥3) at baseline were independent risk factors for adenoma recurrence.
A colonoscopy surveillance interval of 3 years in patients with baseline advanced adenoma can be considered appropriate.
背景/目的:由于存在新发性结肠肿瘤的风险,目前建议在息肉切除术后进行结肠镜监测。然而,亚洲地区针对结肠镜监测的研究较少。本多中心前瞻性研究旨在根据结肠镜息肉切除术后3年的基线腺瘤情况评估进展性腺瘤的发生率。
共有1323例接受结肠镜息肉切除术的患者被前瞻性地分配到11个三级内镜中心进行为期3年的结肠镜监测。根据基线腺瘤特征计算3年后进展性腺瘤的相对风险。
在纳入的1323例患者中,387例(29.3%)接受了随访,平均随访间隔为31.0±9.8个月。监测组基线结肠镜检查时进展性腺瘤患者的比例高于非监测组(34.4%对25.7%)。随访期间,17例患者(4.4%)出现进展性腺瘤复发。基线为进展性腺瘤的患者进展性腺瘤复发风险是基线为非进展性腺瘤患者的2倍,尽管差异无统计学意义(6.8%[9/133]对3.1%[8/254],P=0.09)。进展性腺瘤复发仅见于男性和年龄≥50岁的受试者。相比之下,随访期间187例患者(48.3%)出现腺瘤复发。男性、年龄较大(≥50岁)以及基线时多发腺瘤(≥3个)是腺瘤复发的独立危险因素。
对于基线为进展性腺瘤的患者,3年的结肠镜监测间隔可被认为是合适的。